Distinct risk groups with different healthcare barriers and acute care use exist in the U.S. population with chronic liver disease
Related Posts
Danpanichkul P, Pang Y, Mahendru T, Tothanarungroj P, Díaz LA, Arab JP, Jatupornpakdee P, Muthiah MD, Duangsonk K, Choi WM, Huang DQ, Kim D, Noureddin[...]
Ahmad J, Dellinger A, Nicoletti P, Barnhart HX, Ghabril M, Fontana RJ, Navarro V, Choi G, Hayashi PH, Gu J, Kleiner D; Drug-Induced Liver Injury[...]
Ramai D, Collins B, Ofosu A, Mohan BP, Jagannath S, Tabibian JH, Girotra M, Barakat MT. Deep Learning Methods in the Imaging of Hepatic and[...]